"Clinically predictive preclinical efficacy testing services at your disposal"

Jussi Halleen - CEO, Pharmatest Services

Current news

Pharmatest attends ASBMR Annual Meeting in Denver

August 28, 2017

Pharmatest Services attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that will be held in Denver, CO, USA on September 8 – 11, 2017. Pharmatest attends the event…

Read More »

Educational seminar in Boston highlights significance of bone metastases

August 24, 2017

Pharmatest Services LLC arranges an educational seminar titled “Significance of Bone Metastases and Targeting Tumor, Bone and Immune System” in hotel Boston Marriott Copley Place in Boston, MA, on…

Read More »

Pharmatest has established a subsidiary in USA

June 7, 2017

Pharmatest Services LLC is a US based CRO operating in Massachusetts, where it offers preclinical efficacy services in oncology and skeletal diseases. The company is a fully owned subsidiary of…

Read More »

Pharmatest launches the first novel humanized mouse model of tumor growth in bone suitable for testing immunotherapies

May 16, 2017

Pharmatest Services Ltd has developed in collaboration with Taconic Biosciences a novel humanized mouse model of tumor growth in bone that can be used for testing immunotherapies. Testing compound…

Read More »

Pharmatest attends AACR Annual Meeting in Washington

March 13, 2017

Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in Washington, D.C., USA on April 1 – 5, 2017. Pharmatest attends the event with a booth (#3538)…

Read More »


February 22, 2017

Pharmatest Services Ltd has joined two California-based organizations Biocom and Science Exchange. Biocom is the largest life science organization in California, and Science Exchange is the leading…

Read More »


January 18, 2017

Pharmatest Services Ltd attends the Tumor Models conference in San Francisco, CA, on January 24 – 26. Pharmatest is sponsoring the conference and holds a scientific oral presentation and poster…

Read More »

Pharmatest Services Ltd attends EORTC-NCI-AACR Meeting in Munich

November 22, 2016

Pharmatest Services Ltd attends the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics that will be held in Munich, Germany on November 29 – December 2, 2016.…

Read More »

Pharmatest collaborates with Envigo in preclinical studies

October 12, 2016

Pharmatest has started a successful collaboration in preclinical studies with one of the world’s leading CROs. The collaboration with Envigo includes the provision of specialised bone safety…

Read More »

Pharmatest Services Ltd invests in latest bone imaging technologies

October 7, 2016

Pharmatest Services Ltd has purchased two new equipment for bone imaging with most advanced latest technologies, the SkyScan 1276 high resolution desktop in vivo µCT system of Bruker, and the Faxitron…

Read More »